SUPPLEMENT

Q1 2022 — Financial statements (US GAAP)

Q1 2022PDF · 8 pages112 KB
ASML - Summary US GAAP Consolidated Statements of Operations
Three months ended,
Apr 4, Apr 3,
(unaudited, in millions €, except per share data) 2021 2022
Net system sales 3,128.8 2,287.2
Net service and field option sales 1,235.1 1,247.2
Total net sales 4,363.9 3,534.4
Total cost of sales (2,011.5) (1,803.4)
Gross profit 2,352.4 1,731.0
Research and development costs (623.4) (738.7)
Selling, general and administrative costs (168.4) (207.7)
Income from operations 1,560.6 784.6
Interest and other, net (12.1) (15.6)
Income before income taxes 1,548.5 769.0
Income tax expense (230.3) (114.4)
Income after income taxes 1,318.2 654.6
Profit related to equity method investments 13.2 40.7
Net income 1,331.4 695.3
Basic net income per ordinary share 3.21 1.73
Diluted net income per ordinary share 3.20 1.73
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 415.3 401.1
Diluted 415.8 401.5
ASML - Ratios and Other Data
Three months ended,
Apr 4, Apr 3,
(unaudited, in millions €, except otherwise indicated) 2021 2022
Gross profit as a percentage of net sales 53.9 % 49.0 %
Income from operations as a percentage of net sales 35.8 % 22.2 %
Net income as a percentage of net sales 30.5 % 19.7 %
Income taxes as a percentage of income before income taxes 14.9 % 14.9 %
Shareholders’ equity as a percentage of total assets 50.1 % 29.1 %
Sales of lithography systems (in units) 1 76 62
Value of booked systems (EUR millions) 2 4,740 6,977
Net bookings lithography systems (in units) 1, 2 120 162
Number of payroll employees in FTEs 27,248 30,861
Number of temporary employees in FTEs 1,561 2,329
1. Lithography systems do not include metrology and inspection systems.
2. Our systems net bookings include all system sales orders for which written authorizations have been accepted.

-- 1 of 8 --

ASML - Summary US GAAP Consolidated Balance Sheets
Dec 31, Apr 3,
(unaudited, in millions €) 2021 2022
ASSETS
Cash and cash equivalents 6,951.8 4,324.1
Short-term investments 638.5 398.5
Accounts receivable, net 3,028.0 3,494.6
Finance receivables, net 1,185.6 1,267.6
Current tax assets 42.0 811.0
Contract assets 164.6 371.3
Inventories, net 5,179.2 6,073.5
Other assets 1,000.5 1,468.2
Total current assets 18,190.2 18,208.8
Finance receivables, net 383.0 191.5
Deferred tax assets 1,098.7 1,141.9
Other assets 1,011.4 934.2
Equity method investments 892.5 940.0
Goodwill 4,555.6 4,555.6
Other intangible assets, net 952.1 923.4
Property, plant and equipment, net 2,982.7 3,159.4
Right-of-use assets - Operating 159.5 172.5
Right-of-use assets - Finance 5.3 4.5
Total non-current assets 12,040.8 12,023.0
Total assets 30,231.0 30,231.8
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities 12,298.0 13,612.8
Total current liabilities 12,298.0 13,612.8
Long-term debt 4,075.0 3,951.7
Deferred and other tax liabilities 240.6 262.2
Contract liabilities 3,225.7 3,292.2
Accrued and other liabilities 251.1 302.5
Total non-current liabilities 7,792.4 7,808.6
Total liabilities 20,090.4 21,421.4
Total shareholders’ equity 10,140.6 8,810.4
Total liabilities and shareholders’ equity 30,231.0 30,231.8

-- 2 of 8 --

ASML - Summary US GAAP Consolidated Statements of Cash Flows
Three months ended,
Apr 4, Apr 3,
(unaudited, in millions €) 2021 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 1,331.4 695.3
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 117.9 131.0
Impairment and loss (gain) on disposal 6.2 12.1
Share-based compensation expense 21.0 11.5
Inventory reserves 34.4 50.2
Deferred tax expense (benefit) (35.8) (39.7)
Equity method investments (21.5) (47.5)
Changes in assets and liabilities (2,395.3) (1,399.0)
Net cash provided by (used in) operating activities (941.7) (586.1)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (189.4) (240.1)
Purchase of intangible assets (7.9) (11.5)
Purchase of short-term investments (608.5) (19.6)
Maturity of short-term investments 499.1 259.5
Net cash provided by (used in) investing activities (306.7) (11.7)
CASH FLOWS FROM FINANCING ACTIVITIES
Purchase of treasury shares (1,567.6) (2,038.2)
Net proceeds from issuance of shares 11.0 21.5
Repayment of debt and finance lease obligations (3.6) (13.5)
Net cash provided by (used in) financing activities (1,560.2) (2,030.2)
Net cash flows (2,808.6) (2,628.0)
Effect of changes in exchange rates on cash 3.0 0.3
Net increase (decrease) in cash and cash equivalents (2,805.6) (2,627.7)
Cash and cash equivalents at beginning of the period 6,049.4 6,951.8
Cash and cash equivalents at end of the period 3,243.8 4,324.1

-- 3 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Statements of
Operations
Three months ended,
Apr 4, Jul 4, Oct 3, Dec 31, Apr 3,
(unaudited, in millions €, except per share data) 2021 2021 2021 2021 2022
Net system sales 3,128.8 2,949.6 4,111.1 3,463.2 2,287.2
Net service and field option sales 1,235.1 1,070.6 1,130.2 1,522.4 1,247.2
Total net sales 4,363.9 4,020.2 5,241.3 4,985.6 3,534.4
Total cost of sales (2,011.5) (1,975.6) (2,529.9) (2,285.0) (1,803.4)
Gross profit 2,352.4 2,044.6 2,711.4 2,700.6 1,731.0
Research and development costs (623.4) (633.8) (609.2) (680.6) (738.7)
Selling, general and administrative costs (168.4) (171.8) (182.9) (202.5) (207.7)
Other income 1 — — — 213.7 —
Income from operations 1,560.6 1,239.0 1,919.3 2,031.2 784.6
Interest and other, net (12.1) (9.8) (10.5) (12.2) (15.6)
Income before income taxes 1,548.5 1,229.2 1,908.8 2,019.0 769.0
Benefit from (provision for) income taxes (230.3) (204.2) (270.9) (316.0) (114.4)
Income after income taxes 1,318.2 1,025.0 1,637.9 1,703.0 654.6
Profit related to equity method investments 13.2 13.2 102.3 70.4 40.7
Net income 1,331.4 1,038.2 1,740.2 1,773.4 695.3
Basic net income per ordinary share 3.21 2.52 4.27 4.39 1.73
Diluted net income per ordinary share 3.20 2.52 4.26 4.38 1.73
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 415.3 411.5 407.9 404.3 401.1
Diluted 415.8 412.0 408.6 405.0 401.5
ASML - Quarterly Summary Ratios and other data
Apr 4, Jul 4, Oct 3, Dec 31, Apr 3,
(unaudited, in millions €, except otherwise indicated) 2021 2021 2021 2021 2022
Gross profit as a percentage of net sales 53.9 % 50.9 % 51.7 % 54.2 % 49.0 %
Income from operations as a percentage of net sales 35.8 % 30.8 % 36.6 % 40.7 % 22.2 %
Net income as a percentage of net sales 30.5 % 25.8 % 33.2 % 35.6 % 19.7 %
Income taxes as a percentage of income before income taxes 14.9 % 16.6 % 14.2 % 15.7 % 14.9 %
Shareholders’ equity as a percentage of total assets 50.1 % 43.5 % 42.1 % 33.5 % 29.1 %
Sales of lithography systems (in units) 2 76 72 79 82 62
Value of booked systems (EUR millions) 3 4,740 8,271 6,179 7,050 6,977
Net bookings lithography systems (in units) 2, 3 120 167 178 191 162
Number of payroll employees in FTEs 27,248 27,777 29,025 29,861 30,861
Number of temporary employees in FTEs 1,561 1,609 1,659 2,155 2,329
1. Other income includes the gain on sale of Berliner Glas subsidiaries.
2. Lithography systems do not include metrology and inspection systems.
3. Our systems net bookings include all system sales orders for which written authorizations have been accepted.

-- 4 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Balance Sheets
Apr 4, Jul 4, Oct 3, Dec 31, Apr 3,
(unaudited, in millions €) 2021 2021 2021 2021 2022
ASSETS
Cash and cash equivalents 3,243.8 5,186.6 4,318.7 6,951.8 4,324.1
Short-term investments 1,411.6 186.7 137.0 638.5 398.5
Accounts receivable, net 2,239.2 2,782.0 3,383.3 3,028.0 3,494.6
Finance receivables, net 2,218.6 1,637.4 1,185.9 1,185.6 1,267.6
Current tax assets 809.7 608.2 289.5 42.0 811.0
Contract assets 107.4 178.9 272.0 164.6 371.3
Inventories, net 4,748.1 5,086.3 4,944.2 5,179.2 6,073.5
Other assets 915.7 922.9 995.0 1,000.5 1,468.2
Held for sale assets 165.5 150.2 152.7 — —
Total current assets 15,859.6 16,739.2 15,678.3 18,190.2 18,208.8
Finance receivables, net 66.6 6.2 139.0 383.0 191.5
Deferred tax assets 700.8 710.5 986.0 1,098.7 1,141.9
Other assets 1,313.4 1,016.4 1,120.9 1,011.4 934.2
Equity method investments 842.5 864.9 963.2 892.5 940.0
Goodwill 4,555.5 4,555.5 4,555.6 4,555.6 4,555.6
Other intangible assets, net 1,014.2 987.7 963.8 952.1 923.4
Property, plant and equipment, net 2,521.6 2,609.4 2,730.3 2,982.7 3,159.4
Right-of-use assets - Operating 179.7 161.8 155.0 159.5 172.5
Right-of-use assets - Finance 164.8 163.9 5.9 5.3 4.5
Total non-current assets 11,359.1 11,076.3 11,619.7 12,040.8 12,023.0
Total assets 27,218.7 27,815.5 27,298.0 30,231.0 30,231.8
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities 6,829.1 8,707.5 9,114.7 12,298.0 13,612.8
Held for sale liabilities 47.2 46.6 47.9 — —
Total current liabilities 6,876.3 8,754.1 9,162.6 12,298.0 13,612.8
Long-term debt 4,634.2 4,619.9 4,105.8 4,075.0 3,951.7
Deferred and other tax liabilities 245.2 247.7 282.6 240.6 262.2
Contract liabilities 1,583.2 1,860.2 2,001.7 3,225.7 3,292.2
Accrued and other liabilities 250.9 240.3 242.9 251.1 302.5
Total non-current liabilities 6,713.5 6,968.1 6,633.0 7,792.4 7,808.6
Total liabilities 13,589.8 15,722.2 15,795.6 20,090.4 21,421.4
Total shareholders’ equity 13,628.9 12,093.3 11,502.4 10,140.6 8,810.4
Total liabilities and shareholders’ equity 27,218.7 27,815.5 27,298.0 30,231.0 30,231.8

-- 5 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Statements of Cash
Flows
Three months ended,
Apr 4, Jul 4, Oct 3, Dec 31, Apr 3,
(unaudited, in millions €) 2021 2021 2021 2021 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 1,331.4 1,038.2 1,740.2 1,773.4 695.3
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 117.9 112.7 116.2 124.2 131.0
Impairment and loss (gain) on disposal 6.2 0.2 (39.8) 17.5 12.1
Share-based compensation expense 21.0 29.0 34.0 33.5 11.5
Gain on sale of subsidiaries — — — (213.7) —
Inventory reserves 34.4 44.0 52.9 49.4 50.2
Deferred tax expense (benefit) (35.8) (7.5) (270.1) (106.2) (39.7)
Equity method investments (21.5) (22.5) (97.3) 91.4 (47.5)
Changes in assets and liabilities (2,395.3) 2,374.8 265.5 4,647.5 (1,399.0)
Net cash provided by (used in) operating activities (941.7) 3,568.9 1,801.6 6,417.0 (586.1)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (189.4) (241.1) (197.0) (273.2) (240.1)
Purchase of intangible assets (7.9) (6.3) (7.9) (17.5) (11.5)
Purchase of short-term investments (608.5) — (50.0) (504.2) (19.6)
Maturity of short-term investments 499.1 1,224.9 99.7 2.7 259.5
Loans issued and other investments — — (124.4) — —
Proceeds from sale of subsidiaries (net of cash disposed) — 12.9 — 316.1 —
Net cash provided by (used in) investing activities (306.7) 990.4 (279.6) (476.1) (11.7)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid — (639.1) — (729.2) —
Purchase of treasury shares (1,567.6) (1,983.9) (2,401.6) (2,607.2) (2,038.2)
Net proceeds from issuance of shares 11.0 13.6 12.3 12.0 21.5
Repayment of debt and finance lease obligations (3.6) (3.2) (2.6) (2.6) (13.5)
Net cash provided by (used in) financing activities (1,560.2) (2,612.6) (2,391.9) (3,327.0) (2,030.2)
Net cash flows (2,808.6) 1,946.7 (869.9) 2,613.9 (2,628.0)
Effect of changes in exchange rates on cash 3.0 (3.9) 2.0 19.2 0.3
Net increase (decrease) in cash and cash equivalents (2,805.6) 1,942.8 (867.9) 2,633.1 (2,627.7)
Cash and cash equivalents at beginning of the period 6,049.4 3,243.8 5,186.6 4,318.7 6,951.8
Cash and cash equivalents at end of the period 3,243.8 5,186.6 4,318.7 6,951.8 4,324.1

-- 6 of 8 --

Notes to the Summary US GAAP Consolidated Financial Statements
Basis of preparation
The accompanying unaudited Summary Consolidated Financial Statements have been prepared in conformity with the
accounting principles generally accepted in the United States of America ("US GAAP").
For further details on our annual disclosure requirements under US GAAP, including our significant accounting policies, these
interim unaudited Summary Consolidated Financial Statements should be read in conjunction with the Consolidated Financial
Statements and Notes included within our 2021 Annual Report based on US GAAP, which is available on www.asml.com.

-- 7 of 8 --

Forward Looking Statements
This document contains statements that are forward-looking, including statements with respect to expected trends, including
trends in end markets and technology industry and business environment trends, rising business costs, outlook and expected
financial results, including expected net sales, gross margin, R&D costs, SG&A costs and estimated annualized effective tax rate,
bookings, expected growth in net sales, full year 2022 expectations including revenue, shipments and expectations for EUV,
DUV, IBM and expectations by market segment, statements made at our 2021 Investor Day including revenue and gross margin
opportunity for 2025 and growth opportunities beyond 2025, expected annual revenue growth rate for the period of 2020-2030,
and our plan to revisit these expectations presented at the 2021 Investor Day, expected revenue recognition, including estimates
of revenue to be recognized in periods after shipment, expected shipments, plans and strategies, including plans to increase
capacity and plans to build additional cleanrooms, customer demand and plans to meet increasing demand, statements with
respect to dividends and share buybacks and financial policy including statements with respect to the 2021-2023 share buyback
program, including the amount of shares intended to be repurchased under the program, ESG strategy improvement and other
non-historical statements. You can generally identify these statements by the use of words like "may", "will", "could", "should",
"project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue", "target", "future",
"progress", "goal" and variations of these words or comparable words. These statements are not historical facts, but rather are
based on current expectations, estimates, assumptions and projections about our business and our future financial results and
readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve
a number of substantial known and unknown risks and uncertainties. These risks and uncertainties include, without limitation,
economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing
capacity utilization for semiconductors, the impact of general economic conditions on consumer confidence and demand for our
customers’ products, performance of our systems, the impact of the COVID-19 outbreak and measures taken to contain it on us,
our suppliers, the global economy and financial markets, the impact of the Russian military actions in the Ukraine and measures
taken in response on the global economy and global financial markets and other factors that may impact ASML’s financial
results, including customer demand and ASML’s ability to obtain parts and components for its products and otherwise meet
demand, the success of technology advances and the pace of new product development and customer acceptance of and
demand for new products, production capacity and our ability to increase capacity to meet demand, the impact of inflation, the
number and timing of systems ordered, shipped and recognized in revenue, and the risk of order cancellation or push out,
supply chain capacity and logistics and constraints on our ability to produce systems to meet demand, trends in the semi-
conductor industry, our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property
disputes and litigation, availability of raw materials, critical manufacturing equipment and qualified employees, trade
environment, import/export and national security regulations and orders and their impact on us, changes in exchange and tax
rates, available liquidity and liquidity requirements, our ability to refinance our indebtedness, available cash and distributable
reserves for, and other factors impacting, dividend payments and share repurchases, results of the share repurchase programs
and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F for the year ended December 31,
2021 and other filings with and submissions to the US Securities and Exchange Commission. These forward-looking statements
are made only as of the date of this document. We undertake no obligation to update any forward-looking statements after the
date of this report or to conform such statements to actual results or revised expectations, except as required by law.

-- 8 of 8 --